Unlocking Opportunity in the Oncology Innovation Landscape Featuring Jonathan Fassberg

Jonathan Fassberg, MBA, Co-founder and Managing Partner of astr Partners, highlights why AVBCC's Global Cancer Research & Innovation Symposium (GCRIS) is a must‑attend event for investors. With cancer innovation accelerating, early‑stage breakthroughs gaining traction, and AI reshaping development, GCRIS offers a rare chance to engage directly with top innovators, pharma leaders, and the broader ecosystem. Join us to explore emerging trends, forge meaningful connections, and identify the opportunities shaping the future of oncology. Learn more at https://avbcc.org/gcris/ #GCRIS #AVBCC #DrugDevelopment #CancerInnovation #CancerResearch #CancerInvestment